Our results indicate that SKOV‐3 tumors display reduced TZM binding compared to AU565 tumors as demonstrated via in vivo MFLI FRET imaging or ex vivo immunohistochemistry (IHC) analysis, although these two HER2 positive cancer cells possess similar levels of HER2 expression. Here, ERBB2 is linked to cancer.